Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Readability of breast self-exam literature

Article Abstract:

The SMOG grading system can be used to assess the readability of women's health literature on breast self-examinations. Patient education booklets have been found to be written at a reading level well beyond the abilities of many patients. Although 50% of patients have a reading level below fifth grade, a study of self-exam literature indicates, on average, most literature is written at the tenth grade level. Breast self-exams are being performed regularly by only 25-35% of the population, so readable materials are essential.

Author: Behan, Barbara A., Reynolds, Audree
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: The Nurse Practitioner
Subject: Health
ISSN: 0361-1817
Year: 1997
Women, Medical examination, Breast examination, Patient education, Literature, Health education, Health education of women

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Low molecular weight heparins: the future of thromboembolic therapy

Article Abstract:

Low molecular weight heparins (LMWHs) are the future of thromboembolic therapy. They have demonstrated efficacy equal to or better than that of heparin and warfarin. They have a longer acting and more selective antithrombotic activity than heparin, and thus there is less likelihood that they will cause adverse responses, among them bleeding and thrombocytopenia. The first LMWH to be approved by the FDA was enoxaparin (Lovenox), approved in 1993 for prophylaxis in those undergoing elective hip surgery.

Author: Dobbin, Kathleen R.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: The Nurse Practitioner
Subject: Health
ISSN: 0361-1817
Year: 1998
Drug therapy, Thromboembolism, Heparin, Enoxaparin

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Role of new selective aromatase inhibitor in therapy for metastatic breast cancer in postmenopausal women

Article Abstract:

Anastrozole (Arimidex) appears to be a good choice for chemotherapy in postmenopausal women with metastatic breast cancer that is no longer responsive to tamoxifen. Anastrozole is a selective aromatase inhibitor that decreases circulating estrogen levels. Clinical trials found it to be as effective as megestrol acetate, with less severe side effects. The recommended dose is 1 mg/day.

Author: Hannaford, Mary
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: The Nurse Practitioner
Subject: Health
ISSN: 0361-1817
Year: 1997
Chemotherapy, Arimidex (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Breast cancer, Health aspects
Similar abstracts:
  • Abstracts: Reducing construction site fires. Controlling exposure to anaesthetic gases. CD on offshore construction
  • Abstracts: Assessing a murmur, saving a life: current trends in the management of hypertrophic cardiomyopathy. A cardiac murmur in a neonate
  • Abstracts: A role change for auxiliaries. Developing a best practice model for care of patients with polydipsia. A high-involvement health care model
  • Abstracts: Family cancer syndromes. Emergency medical help: alerting units quiet fears when you're home alone. Family medical tree: charting your health heritage can be valuable
  • Abstracts: Wound care pain management. Atypical chest pain in the elderly. Sciatic pain and piriformis syndrome
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.